Pinto M, Gill T J, Kunz H W, Dixon-McCarthy B D
Transplantation. 1983 Jun;35(6):607-11. doi: 10.1097/00007890-198306000-00017.
In order to investigate the influence of MHC and non-MHC genes in bone marrow transplantation, various combinations of congenic and inbred strains of rats were used as donors and recipients. A standard regimen of busulfan and cyclophosphamide treatment was used to condition the recipients. The resultant survival patterns of the animals indicated that: (1) a difference across the entire RT1 (MHC) complex is sufficient for the induction of fatal graft-versus-host disease (GVHD) in 100% of the engrafted animals; and (2) the blood group antigens RT2 and RT3, which are controlled by non-MHC genes, do not cause bone marrow graft rejection or GVHD. There were sequential changes of expression in surface alloantigens on the red cells in different donor-recipient combinations without other hematologic changes in the busulfan-cyclophosphamide conditioned bone marrow chimeras.
为了研究主要组织相容性复合体(MHC)和非MHC基因在骨髓移植中的影响,将同基因和近交系大鼠的各种组合用作供体和受体。采用白消安和环磷酰胺治疗的标准方案对受体进行预处理。动物的最终存活模式表明:(1)整个RT1(MHC)复合体的差异足以在100%的移植动物中诱发致命的移植物抗宿主病(GVHD);(2)由非MHC基因控制的血型抗原RT2和RT3不会导致骨髓移植排斥或GVHD。在白消安-环磷酰胺预处理的骨髓嵌合体中,不同供体-受体组合的红细胞表面同种异体抗原表达有顺序变化,而无其他血液学变化。